Gland Pharma’s shares have specialized niche injectables manufacturers, and have been on fire, with the company’s prospects getting a boost following the approval for the...
The Drug Controller General of India (DCGI) has approved the restricted emergency use of the Sputnik V vaccine late Monday night. With this, India now...
Gland Pharma has partnered with the Russian Direct Investment Fund (RDIF) to make up to 252 million doses of Sputnik V, the Covid-19 vaccine developed...
India is expected to grant emergency use authorization for Russia’s Sputnik V COVID-19 vaccine this month or next, the Russian Direct Investment Fund (RDIF), which markets the...
Russia’s Sputnik V vaccine is 91.4 per cent effective in protecting COVID-19 and has demonstrated 100 per cent efficacy against severe coronavirus cases, the vaccine’s developers said...
Russia’s sovereign wealth fund, Russian Direct Investment Fund (RDIF) has joined hands with Indian pharma company Hetero Labs for producing over 100 million doses per year of the world’s...
Dr Reddy’s Laboratories may begin clinical trials of Russia’s potential coronavirus vaccine in India in the next few weeks, said an executive at the Indian drugmaker...
Russia strongly trusts its COVID-19 developed vaccine and is ready to take legal liability if anything goes wrong, instead of needing buyers to bear full...